US Stock MarketDetailed Quotes

ADVM Adverum Biotechnologies

Watchlist

6.0400
+0.2900+5.04%

Close Nov 22 16:00 ET

6.1900
+0.1500+2.48%

Post 16:09 ET

125.65MMarket Cap-1015P/E (TTM)

Adverum Biotechnologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

11.66%-21.12M

14.65%-19.84M

-3.72%-23.25M

15.90%-90.9M

-15.44%-21.33M

24.82%-23.91M

19.50%-23.25M

22.53%-22.41M

-0.24%-108.09M

28.43%-18.48M

Net income from continuing operations

17.49%-27.13M

41.36%-18.48M

14.69%-24.79M

24.18%-117.17M

27.56%-23.71M

18.06%-32.89M

28.00%-31.51M

23.35%-29.06M

-6.18%-154.54M

4.86%-32.74M

Operating gains losses

----

-59.02%50K

-266.67%-35K

----

--122K

--21K

Depreciation and amortization

-41.02%890K

-37.68%956K

-37.37%997K

-13.54%5.64M

-41.06%1.01M

-15.60%1.51M

-4.30%1.53M

11.72%1.59M

40.54%6.53M

29.50%1.71M

Other non cash items

-90.00%558K

-89.72%533K

-66.32%487K

396.68%13.03M

-22.52%819K

1,042.40%5.58M

361.21%5.18M

39.85%1.45M

10,592.00%2.62M

887.85%1.06M

Change In working capital

187.00%2.11M

-187.65%-6.36M

-125,933.33%-3.78M

-152.48%-8.32M

-154.84%-3.68M

-176.92%-2.43M

-143.74%-2.21M

-99.68%3K

290.18%15.85M

195.90%6.71M

-Change in prepaid assets

357.68%4.65M

-6,270.75%-6.75M

-47.77%515K

-61.87%480K

-70.32%1.4M

-358.68%-1.8M

91.51%-106K

133.81%986K

138.77%1.26M

1,821.54%4.73M

-Change in payables and accrued expense

11,815.56%5.27M

173.13%988K

-3,067.80%-3.74M

-667.14%-5.58M

-332.99%-4.06M

99.26%-45K

-126.49%-1.35M

-147.39%-118K

-40.85%983K

273.61%1.74M

-Change in other current liabilities

----

21.09%-595K

36.18%-552K

-123.68%-3.22M

----

---754K

---865K

364.72%13.61M

----

Cash from discontinued investing activities

Operating cash flow

11.66%-21.12M

14.65%-19.84M

-3.72%-23.25M

15.90%-90.9M

-15.44%-21.33M

24.82%-23.91M

19.50%-23.25M

22.53%-22.41M

-0.24%-108.09M

28.43%-18.48M

Investing cash flow

Cash flow from continuing investing activities

-173.34%-13.35M

-103.47%-2.33M

-202.29%-22.03M

-31.64%96.88M

-542.17%-9.88M

-25.32%18.2M

118.07%67.02M

-74.48%21.53M

80.06%141.72M

-90.65%2.23M

Net PPE purchase and sale

55.35%-221K

55.56%-16K

-5.88%-90K

93.16%-808K

-3.78%-192K

39.93%-495K

99.44%-36K

98.06%-85K

21.87%-11.82M

95.75%-185K

Net investment purchase and sale

-170.22%-13.13M

-103.45%-2.31M

-201.48%-21.94M

-36.38%97.68M

-500.41%-9.69M

-25.80%18.69M

80.42%67.06M

-75.64%21.62M

63.63%153.54M

-91.43%2.42M

Cash from discontinued investing activities

Investing cash flow

-173.34%-13.35M

-103.47%-2.33M

-202.29%-22.03M

-31.64%96.88M

-542.17%-9.88M

-25.32%18.2M

118.07%67.02M

-74.48%21.53M

80.06%141.72M

-90.65%2.23M

Financing cash flow

Cash flow from continuing financing activities

-1,550.00%-116K

119.88M

-88.63%69K

-31.40%166K

-105K

-97.79%8K

-74.68%607K

-35.47%242K

Net common stock issuance

--0

---380K

--119.74M

----

--0

----

Proceeds from stock option exercised by employees

--0

7.32%264K

--139K

-19.44%489K

0.00%242K

--1K

-32.04%246K

--0

-36.24%607K

-35.47%242K

Net other financing activities

----

---420K

---76K

---106K

----

Cash from discontinued financing activities

Financing cash flow

--0

-1,550.00%-116K

--119.88M

-88.63%69K

-31.40%166K

---105K

-97.79%8K

--0

-74.68%607K

-35.47%242K

Net cash flow

Beginning cash position

13.58%129.3M

116.38%151.58M

8.52%76.98M

93.29%70.93M

24.25%108.02M

20.62%113.84M

-23.98%70.06M

93.29%70.93M

-42.14%36.7M

127.25%86.93M

Current changes in cash

-492.17%-34.47M

-150.90%-22.29M

8,587.83%74.61M

-82.35%6.04M

-94.01%-31.04M

21.76%-5.82M

1,873.94%43.78M

-101.59%-879K

228.10%34.24M

-927.55%-16M

End cash Position

-12.21%94.83M

13.58%129.3M

116.38%151.58M

8.52%76.98M

24.25%108.02M

20.62%113.84M

-23.98%70.06M

93.29%70.93M

Free cash flow

12.55%-21.35M

14.71%-19.86M

-3.72%-23.34M

23.52%-91.71M

-15.33%-21.52M

25.20%-24.41M

34.06%-23.29M

32.45%-22.5M

2.48%-119.91M

38.14%-18.66M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	11.66%-21.12M	14.65%-19.84M	-3.72%-23.25M	15.90%-90.9M	-15.44%-21.33M	24.82%-23.91M	19.50%-23.25M	22.53%-22.41M	-0.24%-108.09M	28.43%-18.48M
Net income from continuing operations	17.49%-27.13M	41.36%-18.48M	14.69%-24.79M	24.18%-117.17M	27.56%-23.71M	18.06%-32.89M	28.00%-31.51M	23.35%-29.06M	-6.18%-154.54M	4.86%-32.74M
Operating gains losses	----	----	----	-59.02%50K	-266.67%-35K	----	----	----	--122K	--21K
Depreciation and amortization	-41.02%890K	-37.68%956K	-37.37%997K	-13.54%5.64M	-41.06%1.01M	-15.60%1.51M	-4.30%1.53M	11.72%1.59M	40.54%6.53M	29.50%1.71M
Other non cash items	-90.00%558K	-89.72%533K	-66.32%487K	396.68%13.03M	-22.52%819K	1,042.40%5.58M	361.21%5.18M	39.85%1.45M	10,592.00%2.62M	887.85%1.06M
Change In working capital	187.00%2.11M	-187.65%-6.36M	-125,933.33%-3.78M	-152.48%-8.32M	-154.84%-3.68M	-176.92%-2.43M	-143.74%-2.21M	-99.68%3K	290.18%15.85M	195.90%6.71M
-Change in prepaid assets	357.68%4.65M	-6,270.75%-6.75M	-47.77%515K	-61.87%480K	-70.32%1.4M	-358.68%-1.8M	91.51%-106K	133.81%986K	138.77%1.26M	1,821.54%4.73M
-Change in payables and accrued expense	11,815.56%5.27M	173.13%988K	-3,067.80%-3.74M	-667.14%-5.58M	-332.99%-4.06M	99.26%-45K	-126.49%-1.35M	-147.39%-118K	-40.85%983K	273.61%1.74M
-Change in other current liabilities	----	21.09%-595K	36.18%-552K	-123.68%-3.22M	----	----	---754K	---865K	364.72%13.61M	----
Cash from discontinued investing activities
Operating cash flow	11.66%-21.12M	14.65%-19.84M	-3.72%-23.25M	15.90%-90.9M	-15.44%-21.33M	24.82%-23.91M	19.50%-23.25M	22.53%-22.41M	-0.24%-108.09M	28.43%-18.48M
Investing cash flow
Cash flow from continuing investing activities	-173.34%-13.35M	-103.47%-2.33M	-202.29%-22.03M	-31.64%96.88M	-542.17%-9.88M	-25.32%18.2M	118.07%67.02M	-74.48%21.53M	80.06%141.72M	-90.65%2.23M
Net PPE purchase and sale	55.35%-221K	55.56%-16K	-5.88%-90K	93.16%-808K	-3.78%-192K	39.93%-495K	99.44%-36K	98.06%-85K	21.87%-11.82M	95.75%-185K
Net investment purchase and sale	-170.22%-13.13M	-103.45%-2.31M	-201.48%-21.94M	-36.38%97.68M	-500.41%-9.69M	-25.80%18.69M	80.42%67.06M	-75.64%21.62M	63.63%153.54M	-91.43%2.42M
Cash from discontinued investing activities
Investing cash flow	-173.34%-13.35M	-103.47%-2.33M	-202.29%-22.03M	-31.64%96.88M	-542.17%-9.88M	-25.32%18.2M	118.07%67.02M	-74.48%21.53M	80.06%141.72M	-90.65%2.23M
Financing cash flow
Cash flow from continuing financing activities	0	-1,550.00%-116K	119.88M	-88.63%69K	-31.40%166K	-105K	-97.79%8K	0	-74.68%607K	-35.47%242K
Net common stock issuance	--0	---380K	--119.74M	----	----	--0	--0	--0	----	----
Proceeds from stock option exercised by employees	--0	7.32%264K	--139K	-19.44%489K	0.00%242K	--1K	-32.04%246K	--0	-36.24%607K	-35.47%242K
Net other financing activities	----	----	----	---420K	---76K	---106K	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	--0	-1,550.00%-116K	--119.88M	-88.63%69K	-31.40%166K	---105K	-97.79%8K	--0	-74.68%607K	-35.47%242K
Net cash flow
Beginning cash position	13.58%129.3M	116.38%151.58M	8.52%76.98M	93.29%70.93M	24.25%108.02M	20.62%113.84M	-23.98%70.06M	93.29%70.93M	-42.14%36.7M	127.25%86.93M
Current changes in cash	-492.17%-34.47M	-150.90%-22.29M	8,587.83%74.61M	-82.35%6.04M	-94.01%-31.04M	21.76%-5.82M	1,873.94%43.78M	-101.59%-879K	228.10%34.24M	-927.55%-16M
End cash Position	-12.21%94.83M	13.58%129.3M	116.38%151.58M	8.52%76.98M	8.52%76.98M	24.25%108.02M	20.62%113.84M	-23.98%70.06M	93.29%70.93M	93.29%70.93M
Free cash flow	12.55%-21.35M	14.71%-19.86M	-3.72%-23.34M	23.52%-91.71M	-15.33%-21.52M	25.20%-24.41M	34.06%-23.29M	32.45%-22.5M	2.48%-119.91M	38.14%-18.66M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data